Studying color vision in with children who gain sight later in life, joining a cancer trial doesn’t improve survival odds, and the first in our books series this year First on this week’s show, Staff Writer Jennifer Couzin-Frankel joins host Sarah Crespi to discuss the pros and cons of participating in clinical trials. Her story challenges the common thinking that participating in a trial is beneficial—even in the placebo group—for cancer patients. Next, Lukas Vogelsang, a postdoctoral fellow in the department of brain and cognitive sciences at the Massachusetts Institute of Technology, talks about research into color vision with “late-sighted” kids. Studying children who were born blind and then later gained vision gave researchers new insights into how vision develops in babies and may even help train computers to see better. Last up on the show is the first in our series of books podcasts on a future to look forward to. Books host Angela Saini talks with author Claire Horn, a researcher based at Dalhousie University’s Health Justice Institute. They discuss the implications of growing babies from fertilized egg to newborn infant—completely outside the body—and Horn’s book Eve: The Disobedient Future of Birth. This week’s episode was produced with help from Podigy. About the Science Podcast Authors: Sarah Crespi; Angela Saini; Jennifer Couzin-Frankel Episode page: https://www.science.org/doi/10.1126/science.z6gdgb4 Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related